Although pathophysiological factors leading to chronic hyperglycemia in different diabetes subgroups (type 1 and type 2 diabetes, MODY) are distinct, metabolic features such as degree of insulin sensitivity/resistance and fatty liver parameters might underpin common mechanisms related to progression towards or free from vascular complications. This evidence concerns the gene INS and type 2 diabetes mellitus.